GBIO Generation Bio Co
565
$2.99
$0.27
(8.28%)
| Watchers | 565 |
| 52-Wk Low | $0.86 |
| 52-Wk High | $6.98 |
| Market Cap | $198.8M |
| Volume | 117,915.00 |
| 52-Wk High | $6.98 |
| 52-Wk Low | $0.86 |
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare ConferenceGlobe Newswire • about 1 month ago
CAMBRIDGE, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases...
Share to Feed
Generation Bio Co. (NASDAQ:GBIO - Get Free Report) was the recipient of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 1,270,000...
This price move could be a signal that GBIO may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...
This indicator may be signaling that GBIO's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
This is a signal that GBIO's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Investors eyeing a purchase of Generation Bio Co (GBIO) stock, but cautious about paying the going market price of 3.35/share, might benefit from considering selling puts among the alternative...
This price move could be a signal that GBIO may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...
Advancements in Genetic Medicine Platforms Highlighted Amid Financial ReviewRelated Stocks: GBIO...
- Company is leveraging proprietary cell-targeted lipid nanoparticle delivery to develop wholly-owned in vivo program for sickle cell disease and beta-thalassemia - Development of breakthrough...
Generation Bio (NASDAQ:GBIO Get Free Report) and Taro Pharmaceutical Industries (NYSE:TARO Get Free Report) are both small-cap medical companies, but which is the better investment...